Choroidal Melanoma Simulating Adenoma of the Retinal Pigment Epithelium Arising at the Site of Congenital Hypertrophy of the Retinal Pigment Epithelium.

Choroidal melanoma Congenital hypertrophy of the retinal pigment epithelium Malignant melanoma Retinal pigment epithelium adenoma

Journal

Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 28 04 2019
accepted: 20 05 2019
entrez: 1 2 2020
pubmed: 1 2 2020
medline: 1 2 2020
Statut: ppublish

Résumé

Neoplasms of the retinal pigment epithelium (RPE) are rare tumors that can simulate choroidal melanoma, but clinical and imaging characteristics often differentiate these lesions. We report a 70-year-old male with an abruptly elevated pigmented lesion that arose at the site of congenital hypertrophy of the RPE and demonstrated associated exudation, as well as feeding and draining vessels, suggestive of RPE adenoma. Optical coherence tomography showed retinal elevation with serous retinal detachment adjacent to the mass, and ultrasonography revealed an abruptly elevated, moderately echodense mass of 6.4-mm thickness. Fluorescein -angiography showed early tumor hypofluorescence, late -tumor hyperfluorescence with staining and leakage, and -retinal vessels buried under the mass, suggestive of a retinal tumor. The patient was monitored with the presumed diagnosis of RPE adenoma, but 3 months later, the growth was documented and fine-needle aspiration biopsy revealed choroidal melanoma. Management with I-125 plaque radiotherapy was performed leading to tumor regression and a thickness of 4.6 mm.

Identifiants

pubmed: 32002404
doi: 10.1159/000501084
pii: oop-0006-0039
pmc: PMC6984159
doi:

Types de publication

Case Reports

Langues

eng

Pagination

39-43

Informations de copyright

Copyright © 2019 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

Am J Ophthalmol. 1978 Jan;85(1):67-71
pubmed: 619687
Arch Ophthalmol. 1999 May;117(5):601-8
pubmed: 10326956
Ophthalmology. 2009 Nov;116(11):2213-6
pubmed: 19744732
Curr Opin Ophthalmol. 2014 May;25(3):177-85
pubmed: 24614143
Br J Ophthalmol. 2008 Mar;92(3):389-91
pubmed: 18303161
Br J Ophthalmol. 1986 Oct;70(10):764-5
pubmed: 2430610
Graefes Arch Clin Exp Ophthalmol. 2006 Jan;244(1):125-8
pubmed: 15983818
Retina. 2005 Sep;25(6):767-71
pubmed: 16141866
Br J Ophthalmol. 1987 Jul;71(7):516-20
pubmed: 3651364

Auteurs

Basil K Williams (BK)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Ocular Oncology Service, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Maura Di Nicola (M)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Ocular Oncology Service, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

J Antonio Lucio-Alvarez (JA)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Asociación para Evitar la Ceguera en México (APEC), Mexico City, Mexico.

David R Lally (DR)

Retina Research Institute, New England Retina Consultants, Springfield, Massachusetts, USA.

Carol L Shields (CL)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Classifications MeSH